Surgery
Volume 143, Issue 1 , Pages 35-42 , January 2008

Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control

  • Iwao Sugitani, MD, PhD

      Affiliations

    • Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan
    • Corresponding Author InformationReprint requests: Iwao Sugitani, MD, PhD, Division of Head and Neck, Cancer Institute Hospital, 3-10-6, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
    • ,
  • Yoshihide Fujimoto, MD, PhD

      Affiliations

    • Division of Head and Neck, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Noriko Yamamoto, MD, PhD

      Affiliations

    • Department of Pathology, Cancer Institute Hospital, Tokyo, Japan

,Accepted 5 June 2007.

References 

  1. Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–953
  2. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088–1095
  3. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–1058
  4. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139–148
  5. Hedinger CE, Williams ED, Sobin LH. Histological typing of thyroid tumours. The WHO international histological classification of tumours. 2nd rev. ed.. Berlin: Springer-Verlag; 1988;
  6. The American Thyroid Association Guideline Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:1–33
  7. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803
  8. Sugitani I, Fujimoto Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocrine J. 1999;46:209–216
  9. Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma (Study of 58 cases with implications for the primary tumor treatment). Cancer. 1984;53:982–992
  10. Schlumberger M, Olivier A, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med. 1988;29:1790–1794
  11. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993;34:1626–1631
  12. Vassilopoulou-Sellin R, Klein MJ, Smith TH, Samaan NA, Frankenthaler RA, Goepfert H, et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer. 1993;71:1348–1352
  13. Sisson VR, Giordino TJ, Jamadar DA, Kazerooni EA, Shapiro B, Gross MD, et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer. 1996;78:2184–2192
  14. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescent with well-differentiated thyroid cancer. J Nucl Med. 1998;39:1531–1536
  15. Brink JS, van Heerden JA, McIver B, Salomao DR, Farley DR, Grant CS, et al. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery. 2000;128:881–886
  16. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am College Surg. 2003;197:191–197
  17. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 1995;80:2041–2045
  18. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892–2899
  19. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol. 2005;63:87–93
  20. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer (The need for selective treatment). Ann Surg Oncol. 1997;4:328–333
  21. Wanebo H, Coburn M, Teates D, Cole B. Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg. 1998;227:912–921
  22. Hay ID. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol. 2006;94:692–700
  23. Fujimoto Y, Obara T, Okamoto T. Textbook of endocrine surgery. In:  Clark OH,  Duh QY,  Kebebew E editor. Papillary thyroid carcinoma: rationale for hemithyroidectomy. 2nd. Philadelphia: Elsevier Saunders; 2005;p. 102–109
  24. Schlumberger M, Tubiana M, de Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986;63:960–967
  25. Pacini F, Cetani F, Micolli P, Mancusi F, Ceccarelli C, Lippi F, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg. 1994;18:600–604
  26. Fujimoto Y, Obara T, Ito Y, Kodama T, Yashiro T, Yamashita T, et al. Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age. Surgery. 1986;100:1098–1107
  27. Tanaka K, Sonoo H, Yamamoto Y, Udagawa K, Arime I, Kunisue H, et al. Analyses of the outcome of locally invasive papillary thyroid carcinomas. Thyroid. 1999;9:1017–1022
  28. Kowalski LP, Filho JG. Results of the treatment of locally invasive thyroid carcinoma. Head Neck. 2002;24:340–344
  29. Sugino K, Kure Y, Ozaki O, Ito K, Matsumoto A. Surgical treatment of locally advanced thyroid cancer. Surgery Today. 1993;23:791–794
  30. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170:467–470
  31. Nishida T, Nakao K, Hashimoto T. Local control in differentiated thyroid carcinoma with extrathyroidal invasion. Am J Surg. 2000;179:86–91
  32. Rouxel A, Hejblum G, Bernier MO, Boëlle PY, Ménégaux F, Mansour G, et al. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2004;89:5362–5368

PII: S0039-6060(07)00370-4

doi: 10.1016/j.surg.2007.06.011

Surgery
Volume 143, Issue 1 , Pages 35-42 , January 2008

Article Tools

* Image Usage & Resolution